全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

血管源性的脑白质高信号与认知功能障碍的研究进展
Research Progress on White Matter Hyperintensity and Cognitive Dysfunction

DOI: 10.12677/ACM.2023.13112488, PP. 17744-17749

Keywords: 血管源性的脑白质高信号,认知功能障碍
White Matter Hyperintensity
, Cognitive Dysfunction

Full-Text   Cite this paper   Add to My Lib

Abstract:

血管源性的脑白质高信号(White matter hyperintensity, WMH)是脑小血管病最常见的影像学标志物之一,目前越来越多的研究认为WHM与认知功能障碍的发生发展密切相关,本文主要对WHM与认知功能的关系进行综述,进一步认识WHM对认知功能的影响。
White matter hypertensity (WMH) is one of the most common imaging markers of cerebral small vessel disease, and more and more studies believe that WHM is closely related to the occurrence and development of cognitive dysfunction. This article reviews the relationship between WHM and cognitive function to further understand the effect of WHM on cognitive function.

References

[1]  Chen, J., Ge, A., Zhou, Y., et al. (2023) White Matter Integrity Mediates the Associations between White Matter Hyper-intensities and Cognitive Function in Patients with Silent Cerebrovascular Diseases. CNS Neuroscience & Therapeutics, 29, 412-428.
https://doi.org/10.1111/cns.14015
[2]  Chen, Y., Wang, X., Guan, L., et al. (2021) Role of White Matter Hyperintensities and Related Risk Factors in Vascular Cognitive Impairment: A Review. Biomolecules, 11, Article 1102.
https://doi.org/10.3390/biom11081102
[3]  Meng, F., Yang, Y. and Jin, G. (2022) Research Progress on MRI for White Matter Hyperintensity of Presumed Vascular Origin and Cognitive Impairment. Frontiers in Neurosci-ence, 13, Article ID: 865920.
https://doi.org/10.3389/fneur.2022.865920
[4]  Zhang, S., Hu, Y., Yang, H., et al. (2023) Value of White Matter Hyperintensity Volume and Total White Matter Volume for Evaluating Cognitive Impairment in Patients with Cerebral Small-Vessel Disease. Frontiers in Aging Neuroscience, 15, Article ID: 1096808.
https://doi.org/10.3389/fnagi.2023.1096808
[5]  Silbert, L.C., Howieson, D.B., Dodge, H., et al. (2009) Cognitive Impairment Risk: White Matter Hyperintensity Progression Matters. Neurology, 73, 120-125.
https://doi.org/10.1212/WNL.0b013e3181ad53fd
[6]  Zeng, W., Chen, Y., Zhu, Z., et al. (2020) Severity of White Matter Hyperintensities: Lesion Patterns, Cognition, and Microstructural Changes. Journal of Cerebral Blood Flow & Metabolism, 40, 2454-2463.
https://doi.org/10.1177/0271678X19893600
[7]  Yang, D., Li, J., Ke, Z., et al. (2023) Subsystem Mechanisms of Default Mode Network Underlying White Matter Hyperintensity-Related Cognitive Impairment. Human Brain Mapping, 44, 2365-2379.
https://doi.org/10.1002/hbm.26215
[8]  Li, B., Du, B., Gu, Z., et al. (2022) Correlations among Peripheral Blood Markers, White Matter Hyperintensity, and Cognitive Function in Patients with Non-Disabling Ischemic Cerebrovascular Events. Frontiers in Aging Neuroscience, 14, Article ID: 1023195.
https://doi.org/10.3389/fnagi.2022.1023195
[9]  Qiao, S., Li, H., Guo, F., et al. (2022) Research Progress on Cognitive Impairment and the Expression of Serum Inflammatory Markers in Patients with White Matter Hyperintensities: A Narrative Review. Annals of Translational Medicine, 10, 421.
https://doi.org/10.21037/atm-22-1016
[10]  Wang, Y.L., Chen, W., Cai, W.J., et al. (2020) Associations of White Matter Hyperintensities with Cognitive Decline: A Longi-tudinal Study. Journal of Alzheimer’s Disease, 73, 759-768.
https://doi.org/10.3233/JAD-191005
[11]  Zwartbol, M.H.T., Ghaznawi, R., Jaarsma-Coes, M., et al. (2022) White Matter Hyperintensity Shape Is Associated with Cognitive Functioning—The SMART-MR Study. Neurobiology of Aging, 120, 81-87.
https://doi.org/10.1016/j.neurobiolaging.2022.08.009
[12]  Chen, T.Y., Chan, P.C., Tsai, C.F., et al. (2022) White Matter Hyperintensities in Dementia with Lewy Bodies Are Associated with Poorer Cognitive Function and Higher De-mentia Stages. Frontiers in Aging Neuroscience, 14, Article ID: 935652.
https://doi.org/10.3389/fnagi.2022.935652
[13]  Karvelas, N. and Elahi, F.M. (2023) White Matter Hyperintensities: Complex Predictor of Complex Outcomes. Journal of the American Heart Association, 12, e030351.
https://doi.org/10.1161/JAHA.123.030351
[14]  Lahna, D., Schwartz, D.L., Woltjer, R., et al. (2022) Venous Col-lagenosis as Pathogenesis of White Matter Hyperintensity. Annals of Neurology, 92, 992-1000.
https://doi.org/10.1002/ana.26487
[15]  Veldsman, M., Kindalova, P., Husain, M., et al. (2020) Spatial Distribution and Cognitive Impact of Cerebrovascular Risk-Related White Matter Hyperintensities. NeuroImage: Clinical, 28, Article ID: 102405.
https://doi.org/10.1016/j.nicl.2020.102405
[16]  Melazzini, L., Mackay, C.E., Bordin, V., et al. (2021) White Matter Hyperintensities Classified According to Intensity and Spatial Location Reveal Specific Associations with Cognitive Per-formance. NeuroImage: Clinical, 30, Article ID: 102616.
https://doi.org/10.1016/j.nicl.2021.102616
[17]  Jimenez-Balado, J., Corlier, F., Habeck, C., et al. (2022) Effects of White Matter Hyperintensities Distribution and Clustering on Late-Life Cognitive Impairment. Scientific Reports, 12, Ar-ticle No. 1955.
https://doi.org/10.1038/s41598-022-06019-8
[18]  Qi, X., Tang, H., Luo, Q., et al. (2019) White Matter Hyperin-tensities Predict Cognitive Decline: A Community-Based Study. Canadian Journal of Neurological Sciences, 46, 383-388.
https://doi.org/10.1017/cjn.2019.47
[19]  Kaskikallio, A., Karrasch, M., Koikkalainen, J., et al. (2019) White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study. Dementia and Geriatric Cognitive Disorders, 48, 297-307.
https://doi.org/10.1159/000506124
[20]  Huang, C.J., Zhou, X., Yuan, X., et al. (2021) Contribution of Inflammation and Hypoperfusion to White Matter Hyperintensi-ties-Related Cognitive Impairment. Frontiers in Neurology, 12, Article ID: 786840.
https://doi.org/10.3389/fneur.2021.786840
[21]  Ding, D., Xiong, Y., Zhao, Q., et al. (2018) White Matter Hyper-intensity Predicts the Risk of Incident Cognitive Decline in Community Dwelling Elderly. Journal of Alzheimer’s Dis-ease, 61, 1333-1341.
https://doi.org/10.3233/JAD-170876
[22]  Kuang, Q., Huang, M., Lei, Y., et al. (2023) Clinical and Cognitive Cor-relates Tractography Analysis in Patients with White Matter Hyperintensity of Vascular Origin. Frontiers in Neurosci-ence, 17, Article ID: 1187979.
https://doi.org/10.3389/fnins.2023.1187979
[23]  Quandt, F., Fischer, F., Schroder, J., et al. (2020) Higher White Matter Hyperintensity Lesion Load Is Associated with Reduced Long-Range Functional Connectivity. Brain Communi-cations, 2, fcaa111.
https://doi.org/10.1093/braincomms/fcaa111
[24]  Zhu, W., Huang, H., Yang, S., et al. (2019) Dysfunctional Ar-chitecture Underlies White Matter Hyperintensities with and without Cognitive Impairment. Journal of Alzheimer’s Dis-ease, 71, 461-476.
https://doi.org/10.3233/JAD-190174
[25]  Wang, S., Zhang, F., Huang, P., et al. (2022) Superficial White Matter Microstructure Affects Processing Speed in Cerebral Small Vessel Disease. Human Brain Mapping, 43, 5310-5325.
https://doi.org/10.1002/hbm.26004
[26]  Vergoossen, L.W.M., Jansen, J.F.A., van Sloten, T.T., et al. (2021) Inter-play of White Matter Hyperintensities, Cerebral Networks, and Cognitive Function in an Adult Population: Diffu-sion-Tensor Imaging in the Maastricht Study. Radiology, 298, 384-392.
https://doi.org/10.1148/radiol.2021202634
[27]  Langen, C.D., Cremers, L.G.M., de Groot, M., et al. (2018) Dis-connection Due to White Matter Hyperintensities Is Associated with Lower Cognitive Scores. Neuroimage, 183, 745-756.
https://doi.org/10.1016/j.neuroimage.2018.08.037
[28]  Garnier-Crussard, A., Desestret, V., Cotton, F., et al. (2020) White Matter Hyperintensities in Ageing: Pathophysiology, Associated Cognitive Disorders and Prevention. La Revue de Médecine Interne, 41, 475-484.
https://doi.org/10.1016/j.revmed.2020.02.009
[29]  Keller, J.A., Kant, I.M.J., Slooter, A.J.C., et al. (2022) Different Cardiovascular Risk Factors Are Related to Distinct White Matter Hyperintensity MRI Phenotypes in Older Adults. NeuroImage: Clinical, 35, Article ID: 103131.
https://doi.org/10.1016/j.nicl.2022.103131
[30]  Song, S., Gaynor, A.M., Gazes, Y., et al. (2022) Physical Activity Moderates the Association between White Matter Hyperintensity Burden and Cognitive Change. Frontiers in Aging Neuroscience, 14, Article ID: 945645.
https://doi.org/10.3389/fnagi.2022.945645
[31]  Boutzoukas, E.M., O’Shea, A., Kraft, J.N., et al. (2022) Higher White Matter Hyperintensity Load Adversely Affects Pre-Post Proximal Cognitive Training Performance in Healthy Older Adults. GeroScience, 44, 1441-1455.
https://doi.org/10.1007/s11357-022-00538-y
[32]  Ye, Q., Zhu, H., Chen, H., et al. (2022) Effects of Cognitive Reserve Proxies on Cognitive Function and Frontoparietal Control Network in Subjects with White Matter Hyperintensi-ties: A Cross-Sectional Functional Magnetic Resonance Imaging Study. CNS Neuroscience & Therapeutics, 28, 932-941.
https://doi.org/10.1111/cns.13824
[33]  Erkinjuntti, T., Roman, G. and Gauthier, S. (2004) Treatment of Vascular Dementia—Evidence from Clinical Trials with Cholinesterase Inhibitors. Journal of the Neurological Sciences, 226, 63-66.
https://doi.org/10.1016/j.jns.2004.09.018
[34]  Farlow, M.R. (2006) Use of Antidementia Agents in Vascular De-mentia: Beyond Alzheimer Disease. Mayo Clinic Proceedings, 81, 1350-1358.
https://doi.org/10.4065/81.10.1350
[35]  Farooq, M.U., Min, J., Goshgarian, C., et al. (2017) Pharmacotherapy for Vascular Cognitive Impairment. CNS Drugs, 31, 759-76.
https://doi.org/10.1007/s40263-017-0459-3
[36]  Craig, D. and Birks, J. (2005) Rivastigmine for Vascular Cognitive Impairment. Cochrane Database of Systematic Reviews, Article No. CD004744.
https://doi.org/10.1002/14651858.CD004744.pub2
[37]  Shi, X., Ren, G., Cui, Y., et al. (2022) Comparative Efficacy and Acceptability of Cholinesterase Inhibitors and Memantine Based on Dosage in Patients with Vascular Cognitive Impairment: A Network Meta-Analysis. Current Alzheimer Research, 19, 133-145.
https://doi.org/10.2174/1567205019666220120112301
[38]  Birks, J. and Grimley Evans, J. (2009) Ginkgo Biloba for Cognitive Impairment and Dementia. Cochrane Database of Systematic Reviews, CD003120.
https://doi.org/10.1002/14651858.CD003120.pub3
[39]  Lu, H., Dang, M., Chen, K., et al. (2023) Naoxin’an Cap-sules Protect Brain Function and Structure in Patients with Vascular Cognitive Impairment. Frontiers in Pharmacology 14, Article ID: 1129125.
https://doi.org/10.3389/fphar.2023.1129125
[40]  Feng, M., Lu, J., May, B.H., et al. (2016) Chinese Herbal Medi-cine for Patients with Vascular Cognitive Impairment No Dementia: Protocol for a Systematic Review. BMJ Open, 6, e010295.
https://doi.org/10.1136/bmjopen-2015-010295

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133